Infant weight (where they were only receiving own mother's milk) at the end of the study (grams) ( · increasing breast milk production in mothers of non‐hospitalised term infants
1 finding from 1 review
Volume of breast milk at the latest time measured (mL) ‐ domperidone, metoclopramide, sulpiride ( · increasing breast milk production in mothers of non‐hospitalised term infants
1 finding from 1 review
Adverse effects for the infant or mother · increasing breast milk production in mothers of non‐hospitalised term infants
1 finding from 1 review
Breastfeeding · increasing breast milk production in mothers of non‐hospitalised term infants
1 finding from 1 review
Infant weight (where they were only receiving own mother's milk) at the end of the study (grams) ( · increasing breast milk production in mothers of non‐hospitalised term infants
1 finding from 1 review
Volume of breast milk at the latest time measured (mL) ( · increasing breast milk production in mothers of non‐hospitalised term infants
1 finding from 1 review
Adverse effects for the infant or mother · increasing breast milk production in mothers of non‐hospitalised term infants
1 finding from 1 review
Incarceration at 3 months · summary findings of female review
It is very uncertain whether cognitive behavioural therapy and standard therapy changes incarceration at 3 months compared with treatment (very low certainty).
2 findings from 1 review
Reincarceration at 9 months · female offenders
Collaborative case management showed no clear difference in reincarceration at 9 months compared with treatment (low certainty).
1 finding from 1 review
Arrests · female offenders
Collaborative case management showed no clear difference in number of arrests compared with treatment (low certainty).
1 finding from 1 review
Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether specific antipsychotic changes tardive dyskinesia: not improved to a clinically important extent compared with other drugs (very low certainty).
1 finding from 1 review
Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether specific antipsychotic changes tardive dyskinesia: deterioration of symptoms compared with other drugs (very low certainty).
1 finding from 1 review
Mental state ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse effect: any ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse effect: extrapyramidal symptoms ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Social confidence, social inclusion, social networks, or personalised quality of life ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Live birth rate per woman · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin showed no clear difference in live birth rate per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin probably leads to higher adverse events (gastrointestinal) per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Clinical pregnancy rate · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin probably leads to higher clinical pregnancy rate per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Menstrual frequency per woman · Women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Metformin may leads to higher menstrual frequency per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review